Mel-Mont Medical is a medical device company that develops n-Vintro mRNA technology device for the prevention of HPV-HR related cancers.
Mel-Mont Medical has raised $250K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.
Mel-Mont Medical is headquartered in Doral, United States.
Mel-Mont Medical is a medical device company that develops n-Vintro mRNA technology device for the prevention of HPV-HR related cancers.
Mel-Mont Medical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mel-Mont Medical — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/mel-mont-medical. Accessed August 18, 2026.
VCBacked. (2025). Mel-Mont Medical — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/mel-mont-medical
{{cite web |title=Mel-Mont Medical — Funding & Investors |url=https://www.vcbacked.co/company/mel-mont-medical |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated